EMVI Rectal Cancer — SCE Medical Oncology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — MRI-detected EMVI is an independent adverse prognostic factor associated with higher risk of distant metastases and poorer OS — it influences decisions about neoadjuvant treatment intensity
Extramural vascular invasion (EMVI) detected on MRI is a strong predictor of distant metastatic recurrence and overall survival in rectal cancer. EMVI-positive tumours have approximately 2-3× higher risk of developing distant metastases. It is one of the key factors (alongside T stage, N stage, CRM threat) guiding the intensity of neoadjuvant treatment: EMVI-positive tumours are often treated with more intensive neoadjuvant regimens (TNT) and/or longer intervals before surgery to achieve tumour regression.
Reference: NICE NG151 Colorectal cancer; ESMO 2024 Rectal Cancer; MERCURY Study Group